Valbiotis SA (EPA:ALVAL)
France flag France · Delayed Price · Currency is EUR
1.058
+0.042 (4.13%)
Mar 5, 2026, 5:35 PM CET

Valbiotis Statistics

Total Valuation

Valbiotis has a market cap or net worth of EUR 24.03 million. The enterprise value is 16.15 million.

Market Cap 24.03M
Enterprise Value 16.15M

Important Dates

The last earnings date was Tuesday, March 3, 2026.

Earnings Date Mar 3, 2026
Ex-Dividend Date n/a

Share Statistics

Valbiotis has 23.66 million shares outstanding.

Current Share Class 23.66M
Shares Outstanding 23.66M
Shares Change (YoY) n/a
Shares Change (QoQ) +0.61%
Owned by Insiders (%) 3.01%
Owned by Institutions (%) 3.28%
Float 22.94M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 22.98
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.72
EV / Sales 15.44
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 3.21%
Revenue Per Employee 23,773
Profits Per Employee -214,023
Employee Count 44
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Valbiotis has paid 2,000 in taxes.

Income Tax 2,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -3.09% in the last 52 weeks. The beta is -0.19, so Valbiotis's price volatility has been lower than the market average.

Beta (5Y) -0.19
52-Week Price Change -3.09%
50-Day Moving Average 0.89
200-Day Moving Average 0.83
Relative Strength Index (RSI) 58.19
Average Volume (20 Days) 209,122

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Valbiotis had revenue of EUR 1.05 million and -9.42 million in losses.

Revenue 1.05M
Gross Profit -1.03M
Operating Income -9.49M
Pretax Income -9.42M
Net Income -9.42M
EBITDA -9.38M
EBIT -9.49M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

Cash & Cash Equivalents n/a
Total Debt n/a
Net Cash n/a
Net Cash Per Share n/a
Equity (Book Value) n/a
Book Value Per Share n/a
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow -8.04M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin -97.99%
Operating Margin -907.65%
Pretax Margin -900.10%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Valbiotis does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -39.18%
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2